# A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)

> **NCT03423303** · NA · ENROLLING_BY_INVITATION · sponsor: **Tampere University** · enrollment: 17400 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Prostate cancer screening

## Key facts

- **NCT ID:** NCT03423303
- **Lead sponsor:** Tampere University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2018-04-23
- **Primary completion:** 2037-12-31
- **Final completion:** 2037-12-31
- **Target enrollment:** 17400 (ESTIMATED)
- **Last updated:** 2025-04-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03423303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03423303, "A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03423303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*